Filing excerpt
In October 2025, the Company announced its intention to separate its Orthopaedics business.
Announced in October 2025, this major corporate separation will create significant operational, IT, and HR complexity, likely triggering evaluations for new systems, consulting services, and infrastructure for both the parent company and the new standalone entity.
Filing excerpt
In October 2025, the Company announced its intention to separate its Orthopaedics business.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10kdivestitureGet every 10-K signal for Johnson & Johnson and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/62053662-60d3-4e74-b1c3-faa4475ae25b returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.
{
"signal_id": "62053662-60d3-4e74-b1c3-faa4475ae25b",
"signal_type": "sec-10k",
"signal_subtype": "divestiture",
"detected_at": "2026-02-17T06:28:56.417+00:00",
"company": {
"name": "Johnson & Johnson",
"domain": "jnj.com"
},
"data": {
"detail": "Announced in October 2025, this major corporate separation will create significant operational, IT, and HR complexity, likely triggering evaluations for new systems, consulting services, and infrastructure for both the parent company and the new standalone entity.",
"metrics": {
"timeframe": "multi_year"
},
"summary": "J&J to separate its Orthopaedics business, targeting completion by late 2027 to mid-2028.",
"excerpts": "In October 2025, the Company announced its intention to separate its Orthopaedics business.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/jnj-20251228.htm",
"filing_date": "2026-02-11",
"filing_year": 2026,
"fiscal_year_end": "12/28",
"sales_relevance": "Carve-out support needed",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/62053662-60d3-4e74-b1c3-faa4475ae25b \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"jnj.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.